{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:53:45Z","timestamp":1785887625612,"version":"3.56.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002744","name":"Bar-Ilan University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002744","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>To identify clinical, sonographic, and laboratory characteristics that distinguish between tubal rupture and tubal abortion following methotrexate (MTX) treatment for ectopic pregnancy (EP) and to compare the morbidity associated with these 2 outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This retrospective cohort study included women treated with MTX for EP at Galilee Medical Center between 2012 and 2024. Data on clinical presentation, ultrasound findings, and laboratory values were analyzed. Uregint surgical interventions were classified as tubal rupture or tubal abortion based on intraoperative findings. A comparative analysis between these groups was performed, and multivariable modeling was used to identify predictors of tubal rupture.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Among 280 women treated with MTX, 47 (16.7%) required urgent surgical intervention. Of these, 15 (34.9%) were confirmed as tubal rupture, while 28 (65.1%) were tubal abortion. Women with tubal rupture more frequently presented with free pelvic fluid on transvaginal ultrasound (64.3 vs. 28.6%,\u00a0<jats:italic>P<\/jats:italic>\u2009=\u20090.045) and had significantly higher intraoperative blood loss (433\u2009\u00b1\u2009143\u00a0mL vs. 250\u2009\u00b1\u2009201\u00a0mL,\u00a0<jats:italic>P<\/jats:italic>\u2009=\u20090.001). A multivariable logistic regression model identified free pelvic fluid as an independent predictor of tubal rupture (odds ratio: 6.09, 95% CI 1.23\u201330.09, <jats:italic>P<\/jats:italic>\u2009=\u20090.027). No significant differences in preoperative beta-hCG levels or other clinical symptoms were observed between the groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Tubal rupture and tubal abortion share overlapping clinical features, making differentiation with current diagnostic tools challenging. Free pelvic fluid on ultrasound is a significant indicator of tubal rupture, underscoring the importance of timely surgical intervention. Recognizing that tubal abortion may be a self-limiting condition in some cases offers opportunities to preserve fallopian tube integrity and reduce unnecessary surgeries. Further research is needed to improve diagnostic accuracy and explore conservative management strategies for tubal abortion.<\/jats:p>\n            <jats:p>Date and number of trial registration: December 2024, 0138\u201324-NHR.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00404-025-08069-5","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T08:59:53Z","timestamp":1749113993000},"page":"833-839","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Distinguishing tubal rupture from tubal abortion in ectopic pregnancies after methotrexate treatment: a retrospective cohort study"],"prefix":"10.1007","volume":"312","author":[{"given":"Asal","family":"Darwish","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"avishalom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inshirah","family":"Sgayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana Mustafa","family":"Mikhail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lior","family":"Lowenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ala","family":"Aiob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,5]]},"reference":[{"issue":"1","key":"8069_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12958-021-00761-w.","volume":"19","author":"A Al Naimi","year":"2021","unstructured":"Al Naimi A, Moore P, Br\u00fcggmann D, Krysa L, Louwen F, Bahlmann F (2021) Ectopic pregnancy: a single-center experience over ten years. Reprod Biol Endocrinol 19(1):79. https:\/\/doi.org\/10.1186\/s12958-021-00761-w.","journal-title":"Reprod Biol Endocrinol"},{"issue":"4","key":"8069_CR2","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/s0002-9378(99)70665-4","volume":"180","author":"N Job-Spira","year":"1999","unstructured":"Job-Spira N, Fernandez H, Bouyer J, Pouly JL, Germain E, Coste J (1999) Ruptured tubal ectopic pregnancy: risk factors and reproductive outcome: results of a population-based study in France. Am J Obstet Gynecol 180(4):938\u2013944. https:\/\/doi.org\/10.1016\/s0002-9378(99)70665-4","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"8069_CR3","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00404-020-05749-2","volume":"303","author":"S Baggio","year":"2021","unstructured":"Baggio S, Garzon S, Russo A, Ianniciello CQ, Santi L, Lagan\u00e0 AS, Raffaelli R, Franchi M (2021) Fertility and reproductive outcome after tubal ectopic pregnancy: comparison among methotrexate, surgery and expectant management. Arch Gynecol Obstet 303(1):259\u2013268","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"8069_CR4","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1097\/AOG.0000000000002464","volume":"131","author":"ACOG Practice Bulletin","year":"2018","unstructured":"ACOG Practice Bulletin (2018) No. 191 tubal ectopic pregnancy. Obstet Gynecol 131(2):e65\u2013e77. https:\/\/doi.org\/10.1097\/AOG.0000000000002464","journal-title":"Obstet Gynecol"},{"issue":"1","key":"8069_CR5","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1186\/s12884-020-03350-8","volume":"20","author":"J Zhang","year":"2020","unstructured":"Zhang J, Zhang Y, Gan L, Liu XY, Du SP (2020) Predictors and clinical features of methotrexate (MTX) therapy for ectopic pregnancy. BMC Pregnancy Childbirth 20(1):654. https:\/\/doi.org\/10.1186\/s12884-020-03350-8","journal-title":"BMC Pregnancy Childbirth"},{"key":"8069_CR6","first-page":"754","volume":"77","author":"TG Stovall","year":"1991","unstructured":"Stovall TG, Ling FW, Gray LA (1991) Single-dose methotrexate for treatment of ectopic pregnancy. Obstet Gynecol 77:754\u2013757","journal-title":"Obstet Gynecol"},{"key":"8069_CR7","first-page":"778","volume":"101","author":"KT Barnhart","year":"2003","unstructured":"Barnhart KT, Gosman G, Ashby R, Sammel M (2003) The medical management of ectopic pregnancy: a meta-analysis comparing single dose and multidose regimens. Obstet Gynecol 101:778\u2013784","journal-title":"Obstet Gynecol"},{"key":"8069_CR8","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1056\/NEJMcp0810384","volume":"361","author":"KT Barnhart","year":"2009","unstructured":"Barnhart KT (2009) Clinical practice ectopic pregnancy. N Engl J Med 361:379\u2013387","journal-title":"N Engl J Med"},{"key":"8069_CR9","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.fertnstert.2013.06.013","volume":"100","author":"Practice Committee of American Society for Reproductive Medicine","year":"2013","unstructured":"Practice Committee of American Society for Reproductive Medicine (2013) Medical treatment of ectopic pregnancy: a committee opinion. Fertil Steril 100:638\u2013644","journal-title":"Fertil Steril"},{"key":"8069_CR10","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.fertnstert.2012.09.040","volume":"98","author":"NM van Mello","year":"2012","unstructured":"van Mello NM, Mol F, Ankum WM et al (2012) Ectopic pregnancy: how the diagnostic and therapeutic management has changed. Fertil Steril 98:1066\u20131073","journal-title":"Fertil Steril"},{"key":"8069_CR11","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.fertnstert.2004.03.066","volume":"82","author":"PS Dudley","year":"2004","unstructured":"Dudley PS, Heard MJ, Sangi-Haghpeykar H et al (2004) Characterizing ectopic pregnancies that rupture despite treatment with methotrexate. Fertil Steril 82:1374\u20131378","journal-title":"Fertil Steril"},{"key":"8069_CR12","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S0736-4679(98)00098-5","volume":"16","author":"K Heard","year":"1998","unstructured":"Heard K, Kendall J, Abbott J (1998) Rupture of ectopic pregnancy after medical therapy with methotrexate: a case series. J Emerg Med 16:857\u2013860","journal-title":"J Emerg Med"},{"key":"8069_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0301-2115(99)00188-8","volume":"89","author":"D Roussos","year":"2000","unstructured":"Roussos D, Panidis D, Matalliotakis I, Mavromatidis G, Neonaki M, Mamopoulos M, Koumantakis E (2000) Factors that may predispose to rupture of tubal ectopic pregnancy. Eur J Obstet Gynecol 89:15\u201317","journal-title":"Eur J Obstet Gynecol"},{"issue":"1","key":"8069_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/09513590.2018.1490406","volume":"35","author":"AP Hutchinson","year":"2019","unstructured":"Hutchinson AP, Pereira N, Chung ER, Shah NJ, Zeku M, Chung PH, Rosenwaks Z (2019) Risk factors and human chorionic gonadotropin trends in patients with ruptured tubal ectopic pregnancies despite methotrexate treatment. Gynecol Endocrinol 35(1):49\u201352. https:\/\/doi.org\/10.1080\/09513590.2018.1490406","journal-title":"Gynecol Endocrinol"},{"key":"8069_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ejogrb.2016.11.016","volume":"208","author":"L Bonin","year":"2017","unstructured":"Bonin L, Pedreiro C, Moret S et al (2017) Predictive factors for the methotrexate treatment outcome in ectopic pregnancy: a comparative study of 400 cases. Eur J Obstet Gynecol Reprod Biol 208:23\u201330","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"8069_CR16","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s43032-022-00881-7","volume":"29","author":"A Cohen","year":"2022","unstructured":"Cohen A, Bar-on S, Cohen Y et al (2022) Ruptured ectopic pregnancies following methotrexate treatment: clinical course and predictors for improving patient counseling. Reprod Sci 29:1209\u20131214","journal-title":"Reprod Sci"},{"key":"8069_CR17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ejogrb.2023.04.030","volume":"285","author":"A Aiob","year":"2023","unstructured":"Aiob A, Yousef H, Abu Shqara R, Mustafa Mikhail S, Odeh M, Lowenstein L (2023) Risk factors and prediction of ectopic pregnancy rupture following methotrexate treatment: a retrospective cohort study. Eur J Obstet Gynecol Reprod Biol 285:181\u2013185. https:\/\/doi.org\/10.1016\/j.ejogrb.2023.04.030","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"8069_CR18","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ejogrb.2018.04.020","volume":"225","author":"JH Lee","year":"2018","unstructured":"Lee JH et al (2018) A risk prediction model for medical treatment failure in tubal pregnancy. Eur J Obstet Gynecol Reprod Biol 225:148\u2013154","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"8069_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/09513590.2018.1490406","volume":"35","author":"AP Hutchinson","year":"2019","unstructured":"Hutchinson AP et al (2019) Risk factors and human chorionic gonadotropin trends in patients with ruptured tubal ectopic pregnancies despite methotrexate treatment. Gynecol Endocrinol 35(1):49\u201352","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"8069_CR20","first-page":"590","volume":"93","author":"GH Lipscomb","year":"1999","unstructured":"Lipscomb GH et al (1999) Management of separation pain after single-dose methotrexate therapy for ectopic pregnancy. Obstet Gynecol 93(4):590\u2013593","journal-title":"Obstet Gynecol"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-025-08069-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-025-08069-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-025-08069-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T17:53:28Z","timestamp":1757181208000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-025-08069-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,5]]},"references-count":20,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["8069"],"URL":"https:\/\/doi.org\/10.1007\/s00404-025-08069-5","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,5]]},"assertion":[{"value":"29 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Galilee Medical Center (December 2024, 0138-24-NHR).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Participant consent was unnecessary due to the study\u2019s retrospective design.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}